Jed Latkin Insider Trading
Get free email notifications about insider trading for Jed Latkin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jed Latkin. Jed Latkin is a CEO, COO & CFO in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and a COO and CFO in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and a Interim COO in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB).
Address: 152 W. 57TH STREET 4TH FLOOR NEW YORK 10019 NY
Companies in which Jed Latkin is an Insider
NAVIDEA BIOPHARMACEUTICALS, INC.
Trading Symbol: NAVBIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Jed Latkin: CEO, COO & CFO, COO and CFO, Interim COO
Holdings: 107,997 shares
Current Value: $56,158
Latest Transaction: Feb 17 2021
$NAVB Market Capitalization: $77.59M
$NAVB Previous Close: $0.52
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Jed Latkin
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 17 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Option Exercise | A | 2.56 | 100,000 | 256,000 | 100,000 | |
Aug 18 2020 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Option Exercise | A | 4.70 | 100,000 | 470,000 | 100,000 | |
Aug 18 2020 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Grant | A | 0.00 | 50,000 | 50 | 107,997 | 58 K to 108 K (+86.21 %) |
Jun 04 2020 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Grant | A | 2.62 | 33,997 | 89,072 | 57,997 | 24 K to 58 K (+141.65 %) |
Feb 20 2020 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Buy | P | 1.08 | 5,000 | 5,400 | 17,950 | 13 K to 18 K (+38.61 %) |
Jun 07 2019 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Buy | P | 1.26 | 1,000 | 1,258 | 12,950 | 12 K to 13 K (+8.37 %) |
May 17 2019 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Buy | P | 1.46 | 1,000 | 1,463 | 11,950 | 11 K to 12 K (+9.13 %) |